Small Molecules
30 July 2018
RedHill Biopharma Announces Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease30 July 2018
FDA Accepts File for Cladribine Tablets as Potential Treatment for Relapsing Forms of Multiple Sclerosis27 July 2018
European CHMP Maintains Negative Opinion on Portola Pharmaceuticals’ Betrixaban Following Appeal27 July 2018
Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery disease27 July 2018
Principia Confirms Human CNS Exposure and Good Tolerability of Oral BTK Inhibitor PRN2246News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports